Hormonal contraception during lactation: Systematic review of randomized controlled trials

Contraception

Volumn 68, Issue 4, 2003, Pages 233-238

  Truitt, S T ^a   Fraser, A B ^a   Grimes, D A ^a   Gallo, M F ^a   Schulz, K F ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

Lactation; Oral contraceptives; Systematic review

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE;

BREAST FEEDING; BREAST MILK; CHILD GROWTH; CLINICAL TRIAL; COCHRANE LIBRARY; DATA BASE; DRUG EFFECT; EMBASE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; LACTATION; LACTATION DISORDER; MEDLINE; REVIEW;

EID: 0142250788     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00133-1     Document Type: Article

References (31)

1. Tsui A.O., Wasserheit J.N., Haaga J.G. Reproductive health in developing countries expanding dimensions, building solutions. Panel on Reproductive Health, Committee on Population, Commission on Behavioral and Social Sciences and Education, National Research Council . 1997;National Academy Press, Washington (DC).
2. Conde-Agudelo A., Belizan J.M. Maternal morbidity and mortality associated with interpregnancy interval cross sectional study . BMJ. 321:2000;1255-1259.
3. Setty-Venugopal V, Upadhyay UD. Effects of birth spacing: three to five saves lives. Pop Rep 2002; Series L.
4. Population Reference Bureau. Breastfeeding patterns in the developing world [Wall Chart], 1999.
5. Grimes D.A., Economy K.E. Primary prevention of gynecologic cancers. Am J Obstet Gynecol. 172:1995;227-235.
6. Knijff S.C., Goorissen E.M., Velthuis-te Wierik E.J., Korver T., Grimes D.A. Summary of contraindications to oral contraceptives. 2000;Parthenon Publishing Group, Inc, New York.
7. Diaz S., Croxatto H.B. Contraception in lactating women. Curr Opin Obstet Gynecol. 5:1993;815-822.
8. th ed:1998;Ardent Media Inc, New York.
9. th ed:1994;Williams & Wilkins, Baltimore.
10. Erwin P.C. To use or not use combined hormonal oral contraceptives during lactation. Fam Plann Perspect. 26:1994;26-30, 33.
11. Chi I. The safety and efficacy issues of progestin-only oral contraceptives - an epidemiologic perspective. Contraception. 47:1993;1-21.
12. Hull V.J. The effects of hormonal contraceptives on lactation current findings, methodological considerations, and future priorities . Stud Fam Plann. 12:1981;134-155.
13. Laukaran V.H. Contraceptive choices for lactating women suggestions for postpartum family planning . Stud Fam Plann. 12:1981;156-163.
14. Thomson A.M., Hytten F.E., Black A.E. Lactation and reproduction. Bull World Health Organ. 52:1975;337-349.
15. Tankeyoon M., Dusitsin N., Chalapati S., et al. Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Oral Contraceptives. Contraception. 30:1984;505-522.
16. Miller G.H., Hughes L.R. Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants. Obstet Gynecol. 35:1970;44-50.
17. Semm K., Dittmar F.W. Post partum ovulation inhibition and milk yield . Curr Ther Res Clin Exp. 8:1966;48-51.
18. Velazquez J.G., Gallegos V.C., Lopez A.S., Bondani A. Efecto de la administracion oral diaria de 0.350 mg de noretindrona en la lactancia y en la composicion de la leche. Ginecol Obstet Mex. 40:1976;31-39.
19. Were E.O., Kendall J.Z., Nyongesa P. Randomised clinical trial to determine optimum initiation time of norgestrel-progestin only contraception in Eldoret Teaching Hospital, Kenya. East Afr Med J. 74:1997;103-107.
20. Drury P.J., Crawford M.A., Ayeni O., Pinol A. Fatty acids in human milk and steroidal contraceptives in Hungary and Thailand. Prog Lipid Res. 25:1986;229-233.
21. Gellen J.J., Sas M. Lactation and contraception effect of low dose oral contraceptives on infant's growth during lactation . Orv Hetil. 125:1984;193-196.
22. Bassol S., Nava-Hernandez M.P., Hernandez-Morales C., Trujillo-Macias A.M., Lopez-Lozano M.R., Recio R. Effects of levonorgestrel implant upon TSH and LH levels in male infants during lactation. Int J Gynaecol Obstet. 76:2002;273-277.
23. Schulz K.F., Grimes D.A. Blinding in randomised trials hiding who got what . Lancet. 359:2002;696-700.
24. Sas M., Gellen J.J., Dusitsin N., et al. An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Oral Contraceptives. Contraception. 33:1986;159-178.
25. Effects of hormonal contraceptives on breast milk composition and infant growth. Stud Fam Plann. 19:1988;361-369.
26. Schulz K.F. Subverting randomization in controlled trials. JAMA. 274:1995;1456-1458.
27. Schulz K.F., Grimes D.A. Sample size slippages in randomised trials exclusions and the lost and wayward . Lancet. 359:2002;781-785.
28. Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. Geneva, Switzerland: World Health Organization, 2000.
29. Moher D., Schulz K.F., Altman D.G. The CONSORT statement revised recommendations for improving the quality of reports of parallel-group randomised trials . Lancet. 357:2001;1191-1194.
30. Halpern S.D., Karlawish J.H., Berlin J.A. The continuing unethical conduct of underpowered clinical trials. JAMA. 288:2002;358-362.
31. Redmond G., Godwin A.J., Olson W., Lippman J.S. Use of placebo controls in an oral contraceptive trial methodological issues and adverse event incidence . Contraception. 60:1999;81-85.